Pureos Bioventures to raise new fund in 2022

  • by


Pureos Bioventures, a Swiss VC investing in pre-clinical and clinical-stage drug developers, plans to raise a second fund of approximately CHF 250m-300m by the end of next year, managing partner Martin Münchbach told Unquote.



Source link

Leave a Reply

Your email address will not be published.